@FiercePharma: Teva outgrows Big Pharma in IMS ranking. Report | Follow @FiercePharma
> In a streamlining effort, GSK centralizes security. Story
> Eli Lilly plans to launch 15 new products in China in the next five years, Chief Executive John Lechleiter has said. Report
> Roche says its blockbuster cancer drug Xeloda has been approved by the European Medicines Agency for treating patients with early colon cancer. Report
> GlaxoSmithKline has re-submitted its application to U.S. regulators for a new use of its Avodart drug in preventing prostate cancer. Report
> Pfizer has sued to prevent Teva Pharmaceutical Industries from selling a generic version of the Viagra impotence drug. Report
> The WHO has published guidance on the production of starting materials for active pharmaceutical ingredients, detailing recommendations to ensure product quality while keeping costs down. Report
Biotech News
@FierceBiotech: "Wow": Developers prepare to reap rewards from biotech R&D tax credit. Story | Follow @FierceBiotech
@JohnCFierce: Development is always a crap shoot. My one, absolute, gotta approve this year is Provenge. We'll see... | Follow @JohnCFierce
> GenVec shares implode on pancreatic cancer trial failure. Item
> Renamed Anchor in talks for $30M round, new pact. Report
> Medivation axes 20 percent of staff in follow-up to trial failure. Article
Manufacturing News
> Lilly unloads trials-supply business to Fisher Clinical. Story
> Regulators keep watch over KV, Acino operations. Report
> In streamlining effort, GSK centralizes security. Story
Biotech Research News
> Aura licenses new technology for guiding cancer drugs. Item
> Institutes break ground on San Diego stem cell 'collaboratory'. Report
> Gout therapy could lead to diabetes, obesity treatments. News
And Finally... A federal judge's ruling against gene patents could threaten the entire genetic research industry. Story